200 related articles for article (PubMed ID: 30006677)
21. Neuroendoscopic management of symptomatic septum pellucidum cysts.
Meng H; Feng H; Le F; Lu JY
Neurosurgery; 2006 Aug; 59(2):278-83; discussion 278-83. PubMed ID: 16883168
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.
Kong LW; Chen J; Zhao H; Yao K; Fang SY; Wang Z; Wang YY; Li SW
Sci Rep; 2019 Nov; 9(1):17080. PubMed ID: 31745161
[TBL] [Abstract][Full Text] [Related]
23. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
Chamberlain MC
Neurology; 2014 Jun; 82(23):2147-8. PubMed ID: 24912510
[No Abstract] [Full Text] [Related]
24. Temporal lobe myxoid glioneuronal tumor, PDGFRA p.K385L-mutant with DNA methylation confirmation.
Gilani A; Siddiq Z; Kleinschmidt-DeMasters BK
Brain Pathol; 2022 Sep; 32(5):e13079. PubMed ID: 35562106
[No Abstract] [Full Text] [Related]
25. Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).
Pandith AA; Qasim I; Zahoor W; Shah P; Bhat AR; Sanadhya D; Shah ZA; Naikoo NA
Sci Rep; 2018 Apr; 8(1):6704. PubMed ID: 29712977
[TBL] [Abstract][Full Text] [Related]
26. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
27. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
Wick W; Meisner C; Hentschel B; Platten M; Schilling A; Wiestler B; Sabel MC; Koeppen S; Ketter R; Weiler M; Tabatabai G; von Deimling A; Gramatzki D; Westphal M; Schackert G; Loeffler M; Simon M; Reifenberger G; Weller M
Neurology; 2013 Oct; 81(17):1515-22. PubMed ID: 24068788
[TBL] [Abstract][Full Text] [Related]
28. Axial T2 weighted magnetic resonance image at the level of the lateral ventricles.
Skelton E; Howlett D
BMJ; 2015 Mar; 350():h1609. PubMed ID: 25810506
[No Abstract] [Full Text] [Related]
29. Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases.
Chen SY; Wang W; Wang LM; Lin QT; Zhao GG; Xu G; Lu DH; Piao YS
Histopathology; 2016 Feb; 68(3):378-87. PubMed ID: 26040650
[TBL] [Abstract][Full Text] [Related]
30. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
31. An Innovative Fluorescent Semi-quantitative Methylation-specific PCR Method for the Determination of MGMT Promoter Methylation is Reflecting Intra-tumor Heterogeneity.
Nguyen A; Legrain M; Noel G; Coca A; Meyer Ea N; Schott R; Lasthaus C; Chenard MP; Gaub MP; Lessinger JM; Guenot D; Entz-Werle N
Curr Cancer Drug Targets; 2015; 15(7):624-40. PubMed ID: 26118907
[TBL] [Abstract][Full Text] [Related]
32. The impact of the DNA-repair gene MGMT in malignant gliomas.
Hutterer M
Neuroepidemiology; 2009; 32(1):30-1. PubMed ID: 18997475
[No Abstract] [Full Text] [Related]
33. Potential Role of Methylation Marker in Glioma Supporting Clinical Decisions.
Roszkowski K; Furtak J; Zurawski B; Szylberg T; Lewandowska MA
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834917
[TBL] [Abstract][Full Text] [Related]
34. Intraventricular dysembryoplastic neuroepithelial tumour: case report.
Emmez H; Kale A; Egemen E; Eser P; Kaymaz M; Paşaoğlu A
Neurol Neurochir Pol; 2012; 46(2):192-5. PubMed ID: 22581603
[TBL] [Abstract][Full Text] [Related]
35. Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?
Hegi ME; Stupp R
Neuro Oncol; 2015 Nov; 17(11):1425-7. PubMed ID: 26374690
[No Abstract] [Full Text] [Related]
36. [Case report: asymptomatic isolated aplasia of the septum pellucidum].
Reubelt D; Schmitz BL
Rofo; 2008 Jan; 180(1):59-61. PubMed ID: 18008197
[No Abstract] [Full Text] [Related]
37. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
38. Rosette-forming glioneuronal tumour of the lateral ventricle in a patient with neurofibromatosis 1.
Kemp S; Achan A; Ng T; Dexter MA
J Clin Neurosci; 2012 Aug; 19(8):1180-1. PubMed ID: 22613490
[TBL] [Abstract][Full Text] [Related]
39. The methylation of a panel of genes differentiates low-grade from high-grade gliomas.
Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Kleszcz R; Sherba A; Baer-Dubowska W
Tumour Biol; 2015 May; 36(5):3831-41. PubMed ID: 25563195
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic implication of MGMT promoter methylation, activity and protein expression in cancer patients].
Chen Y; Qi H
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):539-42. PubMed ID: 26705056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
